References and Notes
For reviews regarding isolation, structure, and synthesis of pyranonaphthoquinone
antibiotics, see:
<A NAME="RD02008ST-1A">1a</A>
Brimble MA.
Duncalf LJ.
Nairn MR.
Nat. Prod. Rep.
1999,
16:
267
<A NAME="RD02008ST-1B">1b</A>
Brimble MA.
Nairn MR.
Prabaharan H.
Tetrahedron
2000,
56:
1937
<A NAME="RD02008ST-1C">1c</A>
Sperry J.
Bachu P.
Brimble MA.
Nat. Prod. Rep.
2008, in press; DOI: 10.1039/b708811f
<A NAME="RD02008ST-2">2</A>
Moore HW.
Czerniak R.
Med. Res. Rev.
1981,
1:
249
For racemic syntheses of dimeric pyranonaphthoquinones, see:
<A NAME="RD02008ST-3A">3a</A>
Brimble MA.
Duncalf LJ.
Neville D.
J. Chem. Soc., Perkin Trans. 1
1998,
4165
<A NAME="RD02008ST-3B">3b</A>
Brimble MA.
Lai MYH.
Org. Biomol. Chem.
2003,
1:
4227
<A NAME="RD02008ST-3C">3c</A>
Brimble MA.
Lai MYH.
Org. Biomol. Chem.
2003,
1:
2084
<A NAME="RD02008ST-3D">3d</A> For a racemic synthesis of cardinalin 3, see:
Govender S.
Mmutlane EM.
van Otterlo WAL.
de Koning CB.
Org. Biomol. Chem.
2007,
5:
2433
<A NAME="RD02008ST-4A">4a</A>
Gill M.
Buchanan MS.
Yu J.
J. Chem. Soc., Perkin Trans. 1
1997,
919
<A NAME="RD02008ST-4B">4b</A>
Gill M.
Buchanan MS.
Yu J.
Aust. J. Chem.
1997,
50:
1081
<A NAME="RD02008ST-5">5</A>
Gibson JS.
Andrey O.
Brimble MA.
Synthesis
2007,
2611
<A NAME="RD02008ST-6">6</A>
Kraus GA.
Molina MT.
Walling JA.
J. Chem. Soc., Chem. Commun.
1986,
1568
<A NAME="RD02008ST-7A">7a</A>
Hauser FM.
Rhee RP.
J. Org. Chem.
1978,
43:
178
<A NAME="RD02008ST-7B">7b</A>
Kraus GA.
Sugimoto H.
Tetrahedron Lett.
1978,
19:
2263
For recent reviews on the Hauser-Kraus annulation, see:
<A NAME="RD02008ST-8A">8a</A>
Rathwell K.
Brimble MA.
Synthesis
2007,
643
<A NAME="RD02008ST-8B">8b</A>
Mal D.
Pahari P.
Chem. Rev.
2007,
107:
1892
<A NAME="RD02008ST-9">9</A>
Andrey O.
Sperry J.
Larsen US.
Brimble MA.
Tetrahedron
2008, in press
<A NAME="RD02008ST-10A">10a</A>
Denes B.
Szantay C.
Arch. Pharm.
1958,
342
<A NAME="RD02008ST-10B">10b</A> For a similar example employing molecular bromine, see:
Abaev VT.
Dmitriev AS.
Gutnov AV.
Podelyakin SA.
Butin AV.
J. Heterocycl. Chem.
2006,
43:
1195
<A NAME="RD02008ST-11">11</A>
Brimble MA.
Burgess CV.
Synthesis
2007,
754
<A NAME="RD02008ST-12">12</A>
Mill RJ.
Taylor NJ.
Snieckus V.
J. Org. Chem.
1989,
54:
4372
<A NAME="RD02008ST-13">13</A>
Nayak MK.
Chakraborti AK.
Tetrahedron Lett.
1997,
38:
8749
<A NAME="RD02008ST-14">14</A>
Kaiser F.
Schwink L.
Velder J.
Schmalz H.-H.
J. Org. Chem.
2002,
67:
9248 ; and references therein
<A NAME="RD02008ST-15">15</A>
Compound 9: colorless oil; [α]D
25 -21.8 (c 2.5, CH2Cl2); IR (oil): νmax = 3070, 3049, 2959, 2932, 2894, 1679, 1588, 1450, 1427, 1348, 1330, 1204, 1112 cm-1. 1H NMR (400 MHz, CDCl3): δ = 0.97 [18 H, s, 2 × C(CH3)3], 0.98 (6 H, d, 3
J
HH = 6.0 Hz, 2 × CH3), 2.48 (6 H, s, 2 × C=OCH3), 2.90 (2 H, dd, 2
J
HH = 13.4 Hz, 3
J
HH = 7.5 Hz, 2 × CHH), 3.11 (2 H, dd, 2
J
HH = 13.4 Hz, 3
J
HH = 6.7 Hz, 2 × CHH), 3.81 (6 H, s, 2 × OCH3), 3.90 (6 H, s, 2 × OCH3), 4.27 [2 H, ddq (app. sext), 3
J
HH = 7.5, 6.7, 6.0 Hz, 2 × CH], 7.27 (4 H, m, ArH), 7.38 (8 H, m, ArH), 7.54 (4 H, dd,
J = 8.1, 1.3 Hz, ArH), 7.66 (4 H, dd, J = 8.1, 1.6 Hz, ArH), 7.93 (2 H, dd, J = 8.8, 1.8 Hz, ArH), 8.15 (2 H, d, J = 8.8 Hz, ArH), 8.36 (2 H, d, J = 1.8 Hz, ArH). 13C NMR (100 MHz, CDCl3): δ = 19.1 {2 × Si[C(CH3)3]}, 23.4 (2 × CHCH3), 27.0 {2 × Si[C(CH3)3]}, 32.8 (2 × C=OCH3), 37.0 (2 × CH2), 61.8 (2 × OCH3), 63.7 (2 × OCH3), 69.6 (2 × CH), 120.6 (2 × CHarom), 123.7 (2 × CHarom), 124.8 (2 × Carom), 126.8 (2 × CHarom), 127.4 (8 × CHarom), 127.9 (2 × Carom), 128.3 (2 × Carom), 129.40 (2 × CHarom), 129.43 (2 × CHarom), 134.27 (2 × Carom), 134.31 (2 × Carom), 134.7 (2 × Carom), 135.8 (4 × CHarom), 135.9 (4 × CHarom), 138.6 (2 × Carom), 149.3 (2 × Carom), 151.6 (2 × Carom), 205.3 (2 × C=O). MS-FAB: m/z (%) = 1050 (4) [M]+, 993 (6) [M - C(CH3)3]+, 795 (14), 397 (10), 197 (40), 135 (100). HRMS-FAB: m/z calcd for C66H74O8Si2 [M]+: 1050.4922; found: 1050.4921.
<A NAME="RD02008ST-16">16</A>
Compound 11: cream-colored solid; mp 268-269 °C; [α]D
24 +36.2 (c 0.12, CH2Cl2). IR (CH2Cl2): νmax = 3418, 3053, 2986, 1638, 1421, 1264, 733 cm-1. 1H NMR (300 MHz, CDCl3): δ = 1.44 (6 H, d, 3
J
HH = 6.0 Hz, 2 × CHCH
3), 1.73 (6 H, d, 3
J
HH = 6.6 Hz, 2 × CHCH
3), 2.66 (2 H, dd, 2
J
HH = 16.2 Hz, 3
J
HH = 11.0 Hz, 2 × CHH), 3.11 (2 H, dd, 2
J
HH = 16.2 Hz, 3
J
HH = 1.5 Hz, 2 × CHH), 3.74 (2 H, m, 2 × CHCH3), 3.91 (6 H, s, 2 × OCH3), 3.95 (6 H, s, 2 × OCH3), 5.26 (2 H, q, 3
J
HH = 6.6 Hz, 2 × CHCH3), 7.89 (2 H, dd, 3
J
HH = 8.8 Hz, 4
J
HH = 1.6 Hz, ArH), 8.18 (2 H, d, 3
J
HH = 8.8 Hz, ArH), 8.37 (2 H, d, 4
J
HH = 1.6 Hz, ArH). 13C NMR (75 MHz, CDCl3): δ = 21.8 (2 × CHCH3), 22.4 (2 × CHCH3), 32.0 (2 × CH2), 61.1 (2 × OCH3), 61.4 (2 × OCH3), 69.6 (2 × CH), 71.3 (2 × CH), 120.4 (2 × CHarom), 122.8 (2 × CHarom), 125.5 (2 × Carom), 125.7 (2 × CHarom), 126.6 (2 × Carom), 127.7 (2 × Carom), 129.9 (2 × Carom), 138.3 (2 × Carom), 148.8 (2 × Carom), 149.0 (2 × Carom). MS (EI): m/z (%) = 542 (100) [M]+, 527 (39), 199 (22), 105 (32), 57 (40), 44 (72). HRMS (EI): m/z calcd for C34H38O6 [M]+: 542.2668; found: 542.2667.
<A NAME="RD02008ST-17">17</A>
Compound 1: yellow solid; mp 239-240 °C; [α]D
23 +356.1 (c 0.15, CH2Cl2). IR (CH2Cl2): νmax = 3432, 3025, 1663, 1265, 736, 705 cm-1. 1H NMR (400 MHz, CDCl3): δ = 1.40 (6 H, d, 3
J
HH = 6.1 Hz, 2 × CHCH
3), 1.58 (6 H, d, 3
J
HH = 6.5 Hz, 2 × CHCH
3), 2.31 (2 H, ddd, J
HH = 18.7, 10.2, 4.0 Hz, 2 × CH
axH), 2.82 (2 H, dt, J
HH = 18.7, 2.5 Hz, 2 × CH
eqH), 3.64 (2 H, m, 2 × CHCH3), 4.89 (2 H, m, 2 × CHCH3), 8.02 (2 H, dd, 3
J
HH = 8.0 Hz, 4
J
HH = 1.9 Hz, ArH), 8.20 (2 H, d, 3
J
HH = 8.0, ArH), 8.35 (2 H, 4
J
HH = 1.9 Hz, ArH). 13C NMR (100 MHz, CDCl3): δ = 20.8 (2 × CHCH3), 21.2 (2 × CHCH3), 30.5 (2 × CH2), 68.7 (2 × CH), 70.0 (2 × CH), 125.0 (2 × CHarom), 127.3 (2 × CHarom), 131.4 (2 × CHarom), 131.9 (2 × Carom), 133.0 (2 × Carom), 143.0 (2 × Carom), 144.2 (2 × Carom), 147.0 (2 × Carom), 183.4 (2 × C=O), 183.7 (2 × C=O). MS (EI): m/z (%) = 482 (100) [M]+, 467 (20), 237 (15), 199 (20), 131 (21), 91 (99), 77 (25), 57 (37), 40 (85). HRMS
(EI): m/z calcd for C30H26O6 [M]+: 482.1729; found: 482.1720.